Study: Benefits of Drugs for Children w/ AHHD may be Limited

Parents and teachers found improvements in core ADHD symptoms among 5- to 6-year-old children who took atomoxetine compared with a placebo group, according to a 101-participant study in Pediatrics. However, patients taking atomoxetine had an increased risk of appetite loss, gastrointestinal upset and sedation, and 62% of those who received the drug were still classified as moderately, markedly or severely ill, the study found. Modern Medicine/HealthDay News (3/22) http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Atomoxetine-of-Limited-Value-in-Young-Children-Wit/ArticleNewsFeed/Article/detail/712852?contextCategoryId=40159